Cargando…

Angiotensin-converting enzyme 2, the SARS-CoV-2 cellular receptor, is widely expressed in human myometrium and uterine leiomyoma

OBJECTIVE: Angiotensin-converting-enzyme 2 (ACE2), the cell surface receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is found in a variety of reproductive tissues. The present study evaluated whether uterine fibroids and normal myometrium express ACE2 and, if so, at which t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Racilan, Alexon M, Assis, Wiviane A, Casalechi, Maíra, Spagnolo-Souza, Ananda, Pascoal-Xavier, Marcelo A, Simões-e-Silva, Ana C, Del Puerto, Helen L, Reis, Fernando M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Covid-19 Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287083/ https://www.ncbi.nlm.nih.gov/pubmed/34307238 http://dx.doi.org/10.1177/2284026520954068

Ejemplares similares

Angiotensin‐converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin‐converting enzyme 2 in patients with cardiovascular disease
por: Lebek, Simon, et al.
Publicado: (2020)

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Komiyama, Maki, et al.
Publicado: (2020)

Angiotensin converting enzyme and sodium glucose cotransporter inhibitors alleviate inflammatory effects of SARS-CoV-2 in cardiomyocytes
por: Wong, Chun-Ka, et al.
Publicado: (2022)

The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study
por: Butler-Laporte, Guillaume, et al.
Publicado: (2020)

Angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID‐19 infection in a multi‐site UK acute hospital trust
por: Bean, Daniel M., et al.
Publicado: (2020)

Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study
por: Kim, Ju Hwan, et al.
Publicado: (2020)

Treatment Options Available for COVID-19 and an Analysis on Possible Role of Combination of rhACE2, Angiotensin (1-7) and Angiotensin (1-9) as Effective Therapeutic Measure
por: Muslim, Shahnawaz, et al.
Publicado: (2020)

WCN23-0291 USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEIs) AND ANGIOTENSIN-RECEPTOR BLOCKERS (ARBs) AND INCIDENCE OF PNEUMONIA OR INFLUENZA OR COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Qin, X., et al.
Publicado: (2023)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Coto, Eliecer, et al.
Publicado: (2021)

Challenges in the Practice of Sexual Medicine in the Time of COVID-19 in Portugal
por: Carvalho, Joana, et al.
Publicado: (2020)

COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients
por: Genet, Bastien, et al.
Publicado: (2020)

Low PEEP Mechanical Ventilation and PaO(2)/FiO(2) Ratio Evolution in COVID-19 Patients
por: Ceruti, Samuele, et al.
Publicado: (2021)

Angiotensin II induces reactive oxygen species, DNA damage, and T-cell apoptosis in severe COVID-19
por: Kundura, Lucy, et al.
Publicado: (2022)

COVID‐19, hypertension, and renin‐angiotensin‐aldosterone system inhibitors: Much ado about nothing or real problem to be solved?
por: Tadic, Marijana, et al.
Publicado: (2020)

Influence of blood pressure control and application of renin‐angiotensin‐aldosterone system inhibitors on the outcomes in COVID‐19 patients with hypertension
por: Chen, Renzheng, et al.
Publicado: (2020)

The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients
por: Harky, Amer, et al.
Publicado: (2021)

Association between renin–angiotensin–aldosterone system inhibitor use and COVID‐19 hospitalization and death: a 1.4 million patient nationwide registry analysis
por: Savarese, Gianluigi, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on community-based testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020
por: Fernàndez-López, Laura, et al.
Publicado: (2023)

Better healthcare can reduce the risk of COVID-19 in-hospital post-partum maternal death: evidence from Brazil
por: Leung, Char, et al.
Publicado: (2022)

Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells
por: Kimura, Hiroki, et al.
Publicado: (2020)

NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications
por: Bodansky, Aaron, et al.
Publicado: (2023)

Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications
por: Ming, Yi, et al.
Publicado: (2020)

Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids
por: Pan, Qun, et al.
Publicado: (2008)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant
por: Abraham, Roshini S., et al.
Publicado: (2021)

Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
por: Finney, Lydia J., et al.
Publicado: (2021)

Antidiabetes Agents against Sars-Cov-2 Infection
por: Vitiello, Antonio, et al.
Publicado: (2020)

Re-reading the SARS-COV-2 Epidemic in Bergamo
por: Schena, Daniele, et al.
Publicado: (2020)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
por: Pak, Theodore, et al.
Publicado: (2023)

Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia
por: Harrington, Patrick, et al.
Publicado: (2021)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
por: Wong, Rebecca S. Y.
Publicado: (2020)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

Nutritional status in post SARS-Cov2 rehabilitation patients
por: Gobbi, M., et al.
Publicado: (2022)

Dysphagia and mechanical ventilation in SARS-COV-2 pneumonia: It's real
por: Bordejé Laguna, Luisa, et al.
Publicado: (2022)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

A Cluster of Aspergillosis Associated with SARS-CoV-2
por: VerLee, Kerrie, et al.
Publicado: (2021)

Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c5sj9joi3bb21jeo44a7e4bc9p